×
Investor Relations Contact. Contact: Ashley R. Robinson. LifeSci Advisors. arr@lifesciadvisors.com. Email Alerts Sign-Up. Email. SEC Filings. Press Releases.
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update. August 9, 2023. Investor Relations Contact. Contact: Ashley R. Robinson.
People also ask
DURECT Corporation focuses on the development of pharmaceutical products for pain, central nervous system disorders, cardiovascular disease, ...
Missing: investor relations
Find the latest institutional holdings data for DURECT Corporation Common Stock (DRRX) including shareholders, ownership summaries, and holding activities ...
Find the latest SEC Filings data for DURECT Corporation Common Stock (DRRX) ... DURECT Corporation Common Stock (DRRX) ... Investor Relations · Contact · Careers ...
DURECT Corporation to Participate in Fireside Chat at the H.C. Wainwright BioConnect Investor Conference ... DURECT Corporation (Nasdaq: DRRX) today announced ...
Missing: relations | Show results with:relations
A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and ...
Missing: relations | Show results with:relations
Rating (720,515)
Durect Corp. (DRRX) stock investors activity – investors allocate an average of 2.99% to DRRX, ​based on 720515 active investor portfolios.
DURECT Corporation (NasdaqCM:DRRX) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes ...
Aug 9, 2023 · PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a ...